Lung cancer remains a global cancer problem. Recent studies have focused on the effectiveness of new combinations of immunological and targeted drugs. A clinical observation of the successful use of a combination of locally destructive effects — endobronchial photodynamic therapy and radiation therapy with immunostimulation with domestic recombinant interleukin — 2 in the treatment of a patient with late‑stage lung cancer is presented. To date, 41 months (3.5 years) have passed since the patient’s treatment and diagnosis. The patient’s condition is satisfactory, he does not complain, physical activity is completely preserved.
No takes yet. Share an insight, caveat, or question.
Ivshin et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: